期刊文献+

支气管动脉化疗灌注联合多极射频治疗中晚期肺癌 被引量:3

The treatment for advanced stage lung cancer with bronchial artery infusion combined with radiofrequency ablation
暂未订购
导出
摘要 目的评价支气管动脉化疗灌注联合多极射频治疗中晚期肺癌的临床疗效。方法对32例失去手术机会或放弃手术治疗的中晚期肺癌患者,在进行常规支气管动脉化疗灌注的同时,于首次化疗灌注后2周,在CT引导下对病灶进行多极射频治疗1次。随访并记录术后半年、1年、2年、3年的有效率与患者生存率,与单纯进行常规支气管动脉化疗灌注的38例对照组进行同期有效率与生存率的比较。结果联合治疗组术后半年、1年、2年、3年的有效率/生存率分别为:87.5%/96.9%、71.9%/81.3%、34.4%/46.9%、12.5%/21.9%。对照组有效率/生存率分别为:63.2%/78.9%、36.9%/52.6%、26.3%/36.8%、5.3%/7.9%,联合治疗组有效率与生存率均明显高于对照组,统计学有明显差异(P<0.05)。结论支气管动脉化疗灌注联合多极射频治疗中晚期肺癌,疗效明显优于单纯支气管动脉化疗灌注(P<0.05),同时可明显提高患者的生存率,是一种较为理想、安全有效的综合性治疗手段,值得推广应用。 Objective To evaluate the efficacy of bronchial artery infusion (BAI) combined with radiofrequency ablation (RFA) in advanced stage lung cancer. Methods 32 patients of advanced stage lung cancer, who had lost opportunity of operation or given up operation, while given routine BAI, were treated with CT-guided RFA 2 weeks after the first BAI. All 32 patients were followed-up in half, one, two and three years on efficiency and survival rate, and the results were com- pared with contrastive group of 38 patients treated with routine BAI only. Results The efficiency and survival rate of the combined group and the contrastive group in half, one, two and three years were 87. 5%/96. 9%, 71. 9%/81. 3%, 34.4%/46.9%, 12.5%/21.9% and 63.2%/78.9%, 36.9%/52.6%, 26.3%/36.8%, 5.3%/7.9% respectively. There was significant difference between the two groups (P〈0.05). Conclusion Bronchial Artery Infusion combined with radiofrequency ablation is an ideal, safty, effective comprehensive treatment method for advanced stage lung cancer.
出处 《中国介入影像与治疗学》 CSCD 2007年第2期93-97,共5页 Chinese Journal of Interventional Imaging and Therapy
关键词 肺癌 支气管动脉灌注 射频 CT引导 Lung neoplasms Bronchial artery infusion Radiofrequency ablation CT-guided
  • 相关文献

参考文献4

二级参考文献26

  • 1刘子江 许绍辉 等.选择性支气管动脉灌注治疗不能手术的肺癌[J].中华放射学杂志,1987,21(1):4-8.
  • 2高广如,江苏医药,1992年,18卷,609页
  • 3韩铭钧,中华放射学杂志,1988年,22卷,243页
  • 4Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung[J]. AJR, 2000, 174(1):57-59.
  • 5Sandler AB, Nemunaids J, Denham C, et al. Phase Ⅲ trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-smll cell lung cancer[J]. J Clin Oncol, 2000, 18(1): 122-130.
  • 6JassemJ, Krzakowski M, Roszkowki K, et al. A phase Ⅱ study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life [J]. Lung Cancer, 2002, 35(1): 73-79.
  • 7孙燕 见 孙燕 哈献文.肿瘤内科治疗,临床肿瘤治疗关键[M].南宁:广西科学技术出版社,1999.170-187.
  • 8Pearson AS,Izzo F,Fleming RY,et al.Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.Am J Surg,1999,178:592-9.
  • 9Rose DM,Allegra DP,Bostick PJ,et al.Radiofrequency ablation:a novel primary and adjunctive ablative technique for hepatic malignancies.Am Surg,1999,65:1009-14.
  • 10Bilchik AJ,Rose DM,Allegra DP,et al.Radiofrequency ablation:a minimally invasive technique with multiple applications.Cancer J Sci Am,1999,5:356-61.

共引文献146

同被引文献55

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部